Cuba will seek World Health Organization (WHO) approval of three COVID-19 vaccines, according to the state-run corporation that produces them, even as it begins administering shots en masse to toddlers. Rolando Perez Rodriguez, director of research and development at Bio Cuba Farma, made the announcement during a discussion broadcast by state media on Tuesday evening on a vaccination campaign that aims to immunize more than 90% of the population by November. “There have already been some exchanges in Havana and at the office in Geneva,” Perez said. “Now begins a procedure and exchange to evaluate the documentation delivered,” he added. The Communist-run Caribbean island is currently vaccinating its population at one of the fastest rates in the world with local drugs Abdala, Soberana-2, and Soberana Plus, all authorized for emergency use by local regulators amid a Delta variant-driven surge that has strained its health system.
The country is the only one in the region to develop a vaccine against the virus. Cuba says its vaccines have an efficacy above 90% and initial results are similar to those of other top vaccines significantly reducing transmission, critical illness, and death, though critics have complained those results have yet to be peer-reviewed. The vaccination campaign includes children as young as two with toddlers across the country scheduled to get the first of two shots starting on Thursday, Public Health Ministry official Doctor Maria Elena Soto said during the same broadcast, becoming the first in the world under six years of age to be immunized. The vaccines are based on traditional platforms used to vaccinate young children for decades, versus new genetically engineered ones, giving them a proven security “pedigree” in addition to clinical trials, the Cuban company and local health officials said. Over the past week, Cuba averaged around 7,500 cases per day and nearly 80 deaths.